JENNIE VANDENHOUTEN: Open Payments
NPI 1730596743 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 77 payments from 16 companies in 2025. Trend: 2023 $2,024 · 2024 $2,341 · 2025 $1,646
Food & beverage: $1,448Education: $198
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $477 |
| Regeneron Healthcare Solutions, Inc. | 14 | $422 |
| Janssen Biotech, Inc. | 11 | $225 |
| ABBVIE INC. | 3 | $65 |
| Arcutis Biotherapeutics, Inc. | 2 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Galderma Laboratories, L.P. | 3 | $54 |
| Lilly USA, LLC | 2 | $49 |
| LEO Pharma Inc. | 2 | $39 |
Products named: Bimzelx, DUPIXENT, TREMFYA, Zoryve, Sotyktu, NEMLUVIO, TALTZ, SKYRIZI.
Industry payments across GA — which companies pay providers there.
